ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 326

Implementation of a Treat-to-Target Quality Improvement Program for Rheumatoid Arthritis Management Using Real-Time Patient Reported Outcome Measures

Malka Forman1, Cianna Leatherwood2, Chang Xu1, Eunji Ko1, Bing Lu3, Maura D. Iversen4, Daniel Solomon2 and Sonali Desai2, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: patient outcomes, quality improvement, Rheumatoid arthritis (RA), shared dicision making and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Changing clinical practice patterns and incorporation patient-reported outcome measures (PROMs) for disease activity assessment into routine workflow is challenging. We sought to integrate a treat-to-target (TTT) approach for medication optimization for patients with RA in our practice through: 1) a reliable system to collect disease activity scores (PROMs) using iPads in the waiting room, 2) a multidisciplinary learning collaborative (LC) for providers focused on TTT, and 3) incorporation of patient perspectives on shared decision making (SDM) and treatment satisfaction.

Methods: At an academic medical center rheumatology clinic, patients completed a Routine Assessment of Patient Index Data 3 (RAPID3) survey via an online patient portal or an iPad. RAPID3 scores were uploaded to patient charts and were available for physicians to review during the visit. Rheumatologists were non-randomly allocated to either intervention (N=8) or control (N=13) groups.  Intervention physicians attended monthly LC sessions between August 2017-June 2018 to discuss and develop TTT practices to use during visits with RA patients.  Physician visit notes were retrospectively examined by 2 researchers to identify patients with medication changes and to calculate a “TTT score”.  Mean TTT scores between intervention and control rheumatologists were evaluated using T-test.  Phone calls were made to patients of physicians in the intervention group following a medication change to measure treatment satisfaction using the Treatment Satisfaction Questionnaire for Medication (TSQM) and use of SDM through the 9-item Shared Decision Making Questionnaire (SDM-Q-9). The TSQM and SDM-Q-9 questionnaires are both on 100 point scales and higher numbers reflect positive scores.

Results: From May 2017-April 2018, 2656 RA patients completed RAPID3 surveys with an average completion rate of 70%.  Mean TTT scores among the intervention group rheumatologists were 9% higher than those in the control group (43% vs. 34%, p= 0.0042) (Figure). 72 phone calls were completed to patients of rheumatologists in the intervention group with median[IQR] TSQM score components of 75[58, 92] (effectiveness), 92[83, 100] (side effects), 100[89, 100] (convenience), and 83 [67, 100] (global satisfaction), and median[IQR] SDM-Q-9 score of 96[87, 00].

Conclusion: The results of this non-randomized, quality improvement study show feasibility and utility of electronic PROMs collection methods and real-time integration of PROMs survey scores into the electronic medical record. It also demonstrates the ability of a learning collaborative model to impact TTT practices within a large academic medical practice, as the non-randomized fashion mimics “real-world” experience.

 


Disclosure: M. Forman, None; C. Leatherwood, None; C. Xu, None; E. Ko, None; B. Lu, None; M. D. Iversen, None; D. Solomon, None; S. Desai, None.

To cite this abstract in AMA style:

Forman M, Leatherwood C, Xu C, Ko E, Lu B, Iversen MD, Solomon D, Desai S. Implementation of a Treat-to-Target Quality Improvement Program for Rheumatoid Arthritis Management Using Real-Time Patient Reported Outcome Measures [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/implementation-of-a-treat-to-target-quality-improvement-program-for-rheumatoid-arthritis-management-using-real-time-patient-reported-outcome-measures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-a-treat-to-target-quality-improvement-program-for-rheumatoid-arthritis-management-using-real-time-patient-reported-outcome-measures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology